368 related articles for article (PubMed ID: 8083979)
1. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.
Tan SH; Leong LE; Walker PA; Bernard HU
J Virol; 1994 Oct; 68(10):6411-20. PubMed ID: 8083979
[TBL] [Abstract][Full Text] [Related]
2. The E2 transcriptional repressor can compensate for Sp1 activation of the human papillomavirus type 18 early promoter.
Demeret C; Yaniv M; Thierry F
J Virol; 1994 Nov; 68(11):7075-82. PubMed ID: 7933089
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
Dong G; Broker TR; Chow LT
J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
[TBL] [Abstract][Full Text] [Related]
4. The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element.
Gloss B; Bernard HU
J Virol; 1990 Nov; 64(11):5577-84. PubMed ID: 2170687
[TBL] [Abstract][Full Text] [Related]
5. During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element.
Tan SH; Gloss B; Bernard HU
Nucleic Acids Res; 1992 Jan; 20(2):251-6. PubMed ID: 1311070
[TBL] [Abstract][Full Text] [Related]
6. Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex.
Hou SY; Wu SY; Zhou T; Thomas MC; Chiang CM
Mol Cell Biol; 2000 Jan; 20(1):113-25. PubMed ID: 10594014
[TBL] [Abstract][Full Text] [Related]
7. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.
Ushikai M; Lace MJ; Yamakawa Y; Kono M; Anson J; Ishiji T; Parkkinen S; Wicker N; Valentine ME; Davidson I
J Virol; 1994 Oct; 68(10):6655-66. PubMed ID: 8083999
[TBL] [Abstract][Full Text] [Related]
8. Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes.
Demeret C; Desaintes C; Yaniv M; Thierry F
J Virol; 1997 Dec; 71(12):9343-9. PubMed ID: 9371593
[TBL] [Abstract][Full Text] [Related]
9. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1.
Hoppe-Seyler F; Butz K
Nucleic Acids Res; 1992 Dec; 20(24):6701-6. PubMed ID: 1336181
[TBL] [Abstract][Full Text] [Related]
10. Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure.
Ham J; Steger G; Yaniv M
EMBO J; 1994 Jan; 13(1):147-57. PubMed ID: 8306958
[TBL] [Abstract][Full Text] [Related]
11. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.
Rapp B; Pawellek A; Kraetzer F; Schaefer M; May C; Purdie K; Grassmann K; Iftner T
J Virol; 1997 Sep; 71(9):6956-66. PubMed ID: 9261424
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of E2-mediated repression of the HPV18 P105 promoter.
Thierry F; Howley PM
New Biol; 1991 Jan; 3(1):90-100. PubMed ID: 1645591
[TBL] [Abstract][Full Text] [Related]
13. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
[TBL] [Abstract][Full Text] [Related]
14. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex.
Dostatni N; Lambert PF; Sousa R; Ham J; Howley PM; Yaniv M
Genes Dev; 1991 Sep; 5(9):1657-71. PubMed ID: 1653173
[TBL] [Abstract][Full Text] [Related]
15. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors.
Stubenrauch F; Leigh IM; Pfister H
J Virol; 1996 Jan; 70(1):119-26. PubMed ID: 8523515
[TBL] [Abstract][Full Text] [Related]
16. The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1.
Parks CL; Shenk T
J Biol Chem; 1996 Feb; 271(8):4417-30. PubMed ID: 8626793
[TBL] [Abstract][Full Text] [Related]
17. Overlapping YY1- and aberrant SP1-binding sites proximal to the early promoter of human papillomavirus type 16.
Dong XP; Pfister H
J Gen Virol; 1999 Aug; 80 ( Pt 8)():2097-2101. PubMed ID: 10466808
[TBL] [Abstract][Full Text] [Related]
18. Sp1 and AP2 regulate but do not constitute TATA-less human TAF(II)55 core promoter activity.
Zhou T; Chiang CM
Nucleic Acids Res; 2002 Oct; 30(19):4145-57. PubMed ID: 12364593
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.
Chin MT; Broker TR; Chow LT
J Virol; 1989 Jul; 63(7):2967-76. PubMed ID: 2542607
[TBL] [Abstract][Full Text] [Related]
20. A fluorescence anisotropy study of DNA binding by HPV-11 E2C protein: a hierarchy of E2-binding sites.
Alexander KA; Phelps WC
Biochemistry; 1996 Jul; 35(30):9864-72. PubMed ID: 8703960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
